Rights and permissions
About this article
Cite this article
Second-line docetaxel beneficial in NSCLC. Inpharma Wkly. 1247, 16 (2000). https://doi.org/10.2165/00128413-200012470-00039
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012470-00039